Gene · 8215
Papers1,958
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
141 to 160 of 1,958
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| A novel pathogenic frameshift variant in AXIN2 in a man with polyposis and hypodontia. | Hered Cancer Clin Pract | 2023 | 37626374 | PubTator, text mining | PubMed |
| Regeneration of Pancreatic Beta Cells by Modulation of Molecular Targets Using Plant-Derived Compounds: Pharmacological Mechanisms and Clinical Potential. | Curr Issues Mol Biol | 2023 | 37623211 | PubTator, text mining | PubMed |
| Transcription factor EB (TFEB) improves ventricular remodeling after myocardial infarction by inhibiting Wnt/β-catenin signaling pathway. | PeerJ | 2023 | 37609444 | PubTator, text mining | PubMed |
| GADD45B regulates the carcinogenesis process of chronic atrophic gastritis and the metabolic pathways of gastric cancer. | Front Endocrinol (Lausanne) | 2023 | 37608794 | PubTator, text mining | PubMed |
| Novel insights into biomarkers of progression in Desmoid tumor. | Front Oncol | 2023 | 37601698 | PubTator, text mining | PubMed |
| PI3K/AKT/mTOR signaling transduction pathway and targeted therapies in cancer. | Mol Cancer | 2023 | 37596643 | PubTator, text mining | PubMed |
| PORCN promotes hepatocellular carcinogenesis via Wnt/β-catenin-dependent manner. | Transl Cancer Res | 2023 | 37588740 | PubTator, text mining | PubMed |
| A Review on the Crosstalk between Insulin and Wnt/β-Catenin Signalling for Bone Health. | Int J Mol Sci | 2023 | 37569816 | PubTator, text mining | PubMed |
| The long transcript of lncRNA TMPO-AS1 promotes bone metastases of prostate cancer by regulating the CSNK2A1/DDX3X complex in Wnt/β-catenin signaling. | Cell Death Discov | 2023 | 37542040 | PubTator, text mining | PubMed |
| Infectious Agents Induce Wnt/β-Catenin Pathway Deregulation in Primary Liver Cancers. | Microorganisms | 2023 | 37512809 | PubTator, text mining | PubMed |
| Chondrocyte Homeostasis and Differentiation: Transcriptional Control and Signaling in Healthy and Osteoarthritic Conditions. | Life (Basel) | 2023 | 37511835 | PubTator, text mining | PubMed |
| KY19382 Accelerates Cutaneous Wound Healing via Activation of the Wnt/β-Catenin Signaling Pathway. | Int J Mol Sci | 2023 | 37511501 | PubTator, text mining | PubMed |
| Casein Kinase 2 (CK2): A Possible Therapeutic Target in Acute Myeloid Leukemia. | Cancers (Basel) | 2023 | 37509370 | PubTator, text mining | PubMed |
| Entire Expressed Peripheral Blood Transcriptome in Pediatric Severe Malarial Anemia. | Res Sq | 2023 | 37503086 | PubTator, text mining | PubMed |
| Signaling pathways governing the maintenance of breast cancer stem cells and their therapeutic implications. | Front Cell Dev Biol | 2023 | 37492224 | PubTator, text mining | PubMed |
| Helicobacter pylori-activated fibroblasts as a silent partner in gastric cancer development. | Cancer Metastasis Rev | 2023 | 37460910 | PubTator, text mining | PubMed |
| Combinations of PRI-724 Wnt/β-Catenin Pathway Inhibitor with Vismodegib, Erlotinib, or HS-173 Synergistically Inhibit Head and Neck Squamous Cancer Cells. | Int J Mol Sci | 2023 | 37445628 | PubTator, text mining | PubMed |
| Targeting signaling pathways in osteosarcoma: Mechanisms and clinical studies. | MedComm (2020) | 2023 | 37441462 | PubTator, text mining | PubMed |
| USP25 promotes hepatocellular carcinoma progression by interacting with TRIM21 via the Wnt/β-catenin signaling pathway. | Chin Med J (Engl) | 2023 | 37439386 | PubTator, text mining | PubMed |
| Targeting Wnt/β-Catenin Pathway by Flavonoids: Implication for Cancer Therapeutics. | Nutrients | 2023 | 37432240 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/8215/papers?page=8